IRCT20120215009014N287
Recruiting
Phase 2
Effect of changes in Gonadotropin Realizing Hormone (GnRH) injection time on intrauterine insemination in infertile women: a randomized clinical trial
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Female infertility.
- Sponsor
- Hamedan University of Medical Sciences
- Enrollment
- 316
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age of 18 to 38 years
- •Indication of intrauterine insemination
- •Infertility for at least 10 years
Exclusion Criteria
- •Non\-visibility of the follicle in ultrasound or more than five cells
- •Fallopian tube disorder
- •History of abdominal and pelvic surgery
- •Taking cytotoxic drugs
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Ganirelix in insemination cycles of women with premature luteinizatioinfertilityintrauterine inseminationReproductive Health and Childbirth - Fertility including in vitro fertilisationACTRN12612000153819Mersin University114
Completed
Not Applicable
Comparsion of effects of Gonadotropin Releasing Hormon Agonists and Antagonists in ART cycles in infertile patientsinfertility.female infertilityIRCT201109136626N3Tabriz University of Medical Sciences120
Completed
Not Applicable
Comparison the effect of Gonadotropin releasing hormone agonist administration versus vaginal Progesterone on serum progesterone in luteal phase in ovarian hyperstimulation and intrauterine insemination cycles in unexplained infertilityinfertility.female infertility,unspecifiedIRCT201205159762N1Vice-chancellor for research of Tehran University of Medical Sciences242
Completed
Phase 2
Effect of Gonadotropin-releasing hormone analogue( GnRh-a ) for in vitro fertillization cycles (IVF)IRCT20160722029027N7Shahid Beheshti University of Medical Sciences72
Recruiting
Phase 3
Comparison of the effect of GnRH agonist administration with GNRH antagonist protocol on assisted reproductive methods in patients with reduced ovarian response.IRCT20130603013566N10Vice chancellor for Research,Tabriz University Of Medical Sciences50